FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN

FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN was reported 548 times

These side effects are most commonly reported by patients taking FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN:

# Side effect Count
0 ERYTHEMA 161
1 DRUG INEFFECTIVE 123
2 SKIN BURNING SENSATION 91
3 CONDITION AGGRAVATED 73
4 SKIN EXFOLIATION 69
5 PRODUCT USE ISSUE 54
6 DRY SKIN 52
7 PRURITUS 51
8 SKIN IRRITATION 51
9 INTENTIONAL PRODUCT USE ISSUE 50
10 INTENTIONAL PRODUCT MISUSE 48
11 SKIN HYPERPIGMENTATION 48
12 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43
13 INCORRECT PRODUCT STORAGE 43
14 PRODUCT USE IN UNAPPROVED INDICATION 39
15 RASH 38
16 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31
17 PAIN OF SKIN 29
18 RASH PAPULAR 21
19 SKIN DISCOLOURATION 21
20 PRODUCT STORAGE ERROR 19
21 HYPERSENSITIVITY 17
22 OFF LABEL USE 16
23 SKIN HYPOPIGMENTATION 14
24 APPLICATION SITE ERYTHEMA 13
25 DERMATITIS 13
26 DRUG EFFECT DECREASED 13
27 PARAESTHESIA 13
28 POOR QUALITY PRODUCT ADMINISTERED 13
29 BLISTER 12
30 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12
31 PIGMENTATION DISORDER 11
32 RASH MACULAR 11
33 INCORRECT DRUG ADMINISTRATION DURATION 10
34 INTENTIONAL UNDERDOSE 10
35 OVERDOSE 10
36 SWELLING FACE 10
37 EMOTIONAL DISTRESS 9
38 INTENTIONAL OVERDOSE 9
39 RASH ERYTHEMATOUS 9
40 REBOUND EFFECT 9
41 SCAB 9
42 ACNE 8
43 CHEMICAL INJURY 8
44 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8
45 APPLICATION SITE DISCOLOURATION 7
46 HEADACHE 7
47 PAIN 7
48 ANXIETY 6
49 CHLOASMA 6
50 DIZZINESS 6
51 SCAR 6
52 APPLICATION SITE EXFOLIATION 5
53 DERMATITIS ALLERGIC 5
54 EYE SWELLING 5
55 FALL 5
56 OCHRONOSIS 5
57 SKIN DISCOMFORT 5
58 SKIN FISSURES 5
59 SKIN SWELLING 5
60 THERAPEUTIC RESPONSE UNEXPECTED 5
61 URTICARIA 5
62 DERMATITIS CONTACT 4
63 EXPIRED PRODUCT ADMINISTERED 4
64 EYE PRURITUS 4
65 FEELING HOT 4
66 HAIR GROWTH ABNORMAL 4
67 NAUSEA 4
68 PRODUCT PHYSICAL CONSISTENCY ISSUE 4
69 RASH PRURITIC 4
70 ROSACEA 4
71 SKIN DISORDER 4
72 SKIN FRAGILITY 4
73 SKIN INJURY 4
74 SLEEP DISORDER 4
75 UNDERDOSE 4
76 ADVERSE REACTION 3
77 APPLICATION SITE PAIN 3
78 APPLICATION SITE PRURITUS 3
79 BURNING SENSATION 3
80 DEEP VEIN THROMBOSIS 3
81 DERMATITIS ATOPIC 3
82 DRUG HYPERSENSITIVITY 3
83 DRY EYE 3
84 DYSPNOEA 3
85 FATIGUE 3
86 HYPERAESTHESIA 3
87 INCORRECT PRODUCT ADMINISTRATION DURATION 3
88 INJURY 3
89 JOINT SWELLING 3
90 OCULAR HYPERAEMIA 3
91 PAIN IN EXTREMITY 3
92 PAPULE 3
93 PRODUCT COLOUR ISSUE 3
94 PRODUCT ODOUR ABNORMAL 3
95 PRODUCT QUALITY ISSUE 3
96 PRURITUS GENERALISED 3
97 SKIN TIGHTNESS 3
98 SKIN WARM 3
99 TELANGIECTASIA 3
100 ABDOMINAL PAIN 2
101 APPLICATION SITE DRYNESS 2
102 BLOOD PRESSURE INCREASED 2
103 CHOLECYSTITIS CHRONIC 2
104 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2
105 CONSTIPATION 2
106 DARK CIRCLES UNDER EYES 2
107 DEFORMITY 2
108 DEPRESSED MOOD 2
109 DEPRESSION 2
110 DIARRHOEA 2
111 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2
112 EXPOSURE DURING PREGNANCY 2
113 EYE IRRITATION 2
114 FEELING ABNORMAL 2
115 FLUSHING 2
116 GALLBLADDER CHOLESTEROLOSIS 2
117 GALLBLADDER DISORDER 2
118 GENERAL PHYSICAL HEALTH DETERIORATION 2
119 HAEMATOCRIT DECREASED 2
120 HOT FLUSH 2
121 LIP SWELLING 2
122 LOSS OF CONSCIOUSNESS 2
123 MEDICATION RESIDUE PRESENT 2
124 NEPHROLITHIASIS 2
125 OEDEMA PERIPHERAL 2
126 POST INFLAMMATORY PIGMENTATION CHANGE 2
127 SELF ESTEEM DECREASED 2
128 SKIN HYPERTROPHY 2
129 SKIN SENSITISATION 2
130 SKIN ULCER 2
131 SUNBURN 2
132 SWELLING 2
133 TREATMENT NONCOMPLIANCE 2
134 VISUAL DISTURBANCE 2
135 ABDOMINAL DISCOMFORT 1
136 ABDOMINAL DISTENSION 1
137 ABNORMAL DREAMS 1
138 ABNORMAL SENSATION IN EYE 1
139 ABNORMAL SLEEP-RELATED EVENT 1
140 ACCIDENTAL EXPOSURE 1
141 ACCIDENTAL EXPOSURE TO PRODUCT 1
142 ACUTE HEPATIC FAILURE 1
143 ADMINISTRATION SITE IRRITATION 1
144 AGEUSIA 1
145 ALLERGY TO VACCINE 1
146 ALOPECIA 1
147 AMENORRHOEA 1
148 ANAEMIA 1
149 ANAPHYLACTIC REACTION 1
150 ANHEDONIA 1
151 ANKLE FRACTURE 1
152 APPLICATION SITE ACNE 1
153 APPLICATION SITE IRRITATION 1
154 APPLICATION SITE SWELLING 1
155 APPLICATION SITE URTICARIA 1
156 ARTHRALGIA 1
157 ASCITES 1
158 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 1
159 BACK DISORDER 1
160 BLOOD CREATININE INCREASED 1
161 BLOOD IMMUNOGLOBULIN G INCREASED 1
162 BLOOD MAGNESIUM DECREASED 1
163 BLOOD POTASSIUM DECREASED 1
164 BODY TEMPERATURE DECREASED 1
165 CATARACT 1
166 CEREBROVASCULAR ACCIDENT 1
167 CHEILITIS 1
168 CHEMICAL BURN OF SKIN 1
169 CHEST DISCOMFORT 1
170 CHOKING SENSATION 1
171 CHOLECYSTITIS 1
172 COGNITIVE DISORDER 1
173 CONTACT LENS INTOLERANCE 1
174 CRYING 1
175 DECREASED APPETITE 1
176 DERMATITIS ACNEIFORM 1
177 DERMATOCHALASIS 1
178 DILATED PORES 1
179 DISCHARGE 1
180 DISCOMFORT 1
181 DISEASE PROGRESSION 1
182 DIVERTICULITIS 1
183 DRUG ERUPTION 1
184 DRY MOUTH 1
185 DYSPHAGIA 1
186 EAR DISCOMFORT 1
187 EAR HAEMORRHAGE 1
188 EARLY SATIETY 1
189 ECZEMA 1
190 EMOTIONAL DISORDER 1
191 EPISTAXIS 1
192 EXPIRED DRUG ADMINISTERED 1
193 EYE BURNS 1
194 EYE PAIN 1
195 EYELID EXFOLIATION 1
196 EYELID SKIN DRYNESS 1
197 EYELIDS PRURITUS 1
198 FIBROSIS 1
199 FLUID RETENTION 1
200 FUNGAL INFECTION 1
201 GAIT DISTURBANCE 1
202 GALLBLADDER INJURY 1
203 GASTRIC BYPASS 1
204 GLOMERULAR FILTRATION RATE DECREASED 1
205 HAEMOGLOBIN DECREASED 1
206 HALLUCINATION, VISUAL 1
207 HERNIA REPAIR 1
208 HYDRONEPHROSIS 1
209 HYPERHIDROSIS 1
210 HYPERTENSION 1
211 INCISION SITE PAIN 1
212 INCORRECT DOSE ADMINISTERED 1
213 INFUSION RELATED REACTION 1
214 INJECTION SITE INFLAMMATION 1
215 INJECTION SITE PAIN 1
216 INSOMNIA 1
217 IRON OVERLOAD 1
218 JOINT RANGE OF MOTION DECREASED 1
219 JUGULAR VEIN DISTENSION 1
220 KERATITIS 1
221 LARYNGEAL OEDEMA 1
222 LIFE EXPECTANCY SHORTENED 1
223 LIMB DISCOMFORT 1
224 LIMB INJURY 1
225 LIP DISORDER 1
226 LIP DRY 1
227 LIP ERYTHEMA 1
228 LIP EXFOLIATION 1
229 LIP PAIN 1
230 LIP PRURITUS 1
231 LOCAL REACTION 1
232 LOCAL SWELLING 1
233 LYMPHADENOPATHY 1
234 MALAISE 1
235 MEDICATION RESIDUE 1
236 MEMORY IMPAIRMENT 1
237 MIDDLE INSOMNIA 1
238 MIGRAINE 1
239 MOBILITY DECREASED 1
240 MUSCLE SPASMS 1
241 MUSCLE TIGHTNESS 1
242 MUSCLE TWITCHING 1
243 MUSCULOSKELETAL PAIN 1
244 MYALGIA 1
245 NASAL DISCOMFORT 1
246 NASOPHARYNGITIS 1
247 NECK PAIN 1
248 NEOPLASM SKIN 1
249 NEPHROGENIC SYSTEMIC FIBROSIS 1
250 NERVOUSNESS 1
251 NIGHT SWEATS 1
252 NIGHTMARE 1
253 NO THERAPEUTIC RESPONSE 1
254 NODULE 1
255 OPTIC NEURITIS 1
256 ORAL DISCOMFORT 1
257 OROPHARYNGEAL PAIN 1
258 OSTEOARTHRITIS 1
259 PALPITATIONS 1
260 PAROSMIA 1
261 PATIENT DISSATISFACTION WITH TREATMENT 1
262 PHARYNGEAL PARAESTHESIA 1
263 PHOTOPHOBIA 1
264 PHOTOSENSITIVITY REACTION 1
265 PLASMA CELL MYELOMA 1
266 PLATELET COUNT DECREASED 1
267 PLEURAL EFFUSION 1
268 PLEURITIC PAIN 1
269 POOR QUALITY DRUG ADMINISTERED 1
270 PRE-EXISTING CONDITION IMPROVED 1
271 PRESCRIBED UNDERDOSE 1
272 PRODUCT ADHESION ISSUE 1
273 PRODUCT AVAILABILITY ISSUE 1
274 PRODUCT CONTAINER ISSUE 1
275 PRODUCT PHYSICAL ISSUE 1
276 PRODUCT STORAGE ISSUE 1
277 PSORIASIS 1
278 PYREXIA 1
279 RED BLOOD CELL COUNT DECREASED 1
280 SARCOIDOSIS 1
281 SCRATCH 1
282 SEBORRHOEA 1
283 SELF-MEDICATION 1
284 SENSITIVE SKIN 1
285 SKIN ABRASION 1
286 SKIN ATROPHY 1
287 SKIN DEPIGMENTATION 1
288 SKIN HAEMORRHAGE 1
289 SKIN INDURATION 1
290 SKIN INFLAMMATION 1
291 SKIN LESION 1
292 SKIN NECROSIS 1
293 SKIN REACTION 1
294 SKIN TEXTURE ABNORMAL 1
295 SKIN WRINKLING 1
296 SLEEP APNOEA SYNDROME 1
297 SOMNOLENCE 1
298 STASIS DERMATITIS 1
299 STENT PLACEMENT 1
300 STOMACH DISCOMFORT 1
301 STRABISMUS 1
302 SUPERIOR VENA CAVA SYNDROME 1
303 SWOLLEN TONGUE 1
304 TENDON DISORDER 1
305 THERAPEUTIC RESPONSE DECREASED 1
306 THERAPEUTIC RESPONSE SHORTENED 1
307 THROAT IRRITATION 1
308 THROMBOPHLEBITIS SUPERFICIAL 1
309 THYROID CANCER 1
310 TOOTH ABSCESS 1
311 TRANSFUSION 1
312 TRANSIENT ISCHAEMIC ATTACK 1
313 TREMOR 1
314 TYPE I HYPERSENSITIVITY 1
315 URINARY TRACT INFECTION 1
316 VENOUS THROMBOSIS 1
317 VERTIGO 1
318 VOMITING 1
319 WEIGHT DECREASED 1
320 WHITE BLOOD CELL COUNT DECREASED 1
321 WHITE BLOOD CELL COUNT INCREASED 1
322 WOUND SECRETION 1
323 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1